BAYER SAYS POSITIVE RESULTS FROM PHASE III STUDY OASIS 3 SUPPORT SUBMISSIONS FOR MARKETING AUTHORIZATION FOR ELINZANETANT
Stock Market News in real time
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
28.48 EUR | -0.04% | +4.11% | 30.17B | ||
2,706 PTS | -1.45% | -1.34% | - | ||
- Stock Market
- Stock Market News in real time
- Economy
- Bayer Says Positive Results From Phase Iii Study Oasis 3 Support…